..
The cost can’t be revealed because of a confidentiality clause but Japanese drug maker Shionogi estimates it at US$700 per treatment.
If the Merck price — about US$700 per treatment — can be used for the US, Europe and Japan, I think at least US$1-2 billion in sales will be anticipated for the first several years,” Teshirogi said of Shionogi’s pill.
..
KJ : Malaysia is ordering 150,000 courses of antiviral pills from Merck & Co because of breakthrough infections.
— Melissa Goh (@MelGohCNA) October 7, 2021
• The pills will be given for free to those in category 3-5 who are still symptomatic after 5 days.
• Cost can’t be revealed because of confidentiality clause. pic.twitter.com/ecDIkAn1wb
..
Malaysia today signed a letter of undertaking with Merck to procure the Molnupiravir anti-viral treatment for COVID-19. We will continue to add more treatment options as part of our arsenal to be a COVID-19 resilient nation. This complements our successful vaccination rollout. pic.twitter.com/pIIOrTxd4W
— Khairy Jamaluddin 🇲🇾🌺 (@Khairykj) October 7, 2021
..
1. Malaysia has signed an agreement with Merck Sharp & Dohme to buy 150,000 courses of the Covid-19 antiviral drug molnupiravir.
— BFM News (@NewsBFM) October 7, 2021
Health Minister Khairy Jamaluddin said molnupiravir however cannot prevent infection, and can only benefit those who have contracted the coronavirus. https://t.co/6hMyIEOZvp pic.twitter.com/BuWHfan9Jh
3. A study conducted by MSD found that molnupiravir reduced the risk of hospitalisation or death by 50% for patients with mild to moderate Covid-19.
— BFM News (@NewsBFM) October 7, 2021
The drug was also found to be effective against several variants, including Gamma, Delta and Mu.https://t.co/qJzWGxjW2U
..
..
weehingthong
Pingback: Singapore signs a deal for Merck’s COVID-19 antiviral drug, Molnupiravir | weehingthong